新闻
2024-03-25
NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in the US
孤儿药临床申请
2024-03-25
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
临床结果上市批准ASH会议
2024-03-25
Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response
临床结果寡核苷酸
2024-03-25
临床结果上市批准
2024-03-25
贝达药业IDH1/IDH2小分子双抑制剂获批临床
申请上市临床申请ASH会议
2024-03-25
万泰疫苗「九价HPV疫苗」在中国启动3期临床!
疫苗临床研究
2024-03-25
潜在阿尔茨海默病新疗法!创新抗体登《细胞》子刊
免疫疗法
2024-03-25
首个!强生口服疗法获FDA批准
临床结果上市批准
2024-03-22
并购临床结果临床成功
2024-03-22
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
临床1期寡核苷酸